Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
995,388
-
Share change
-
-377,177
-
Total reported value
-
$5,966,374
-
Price per share
-
$5.99
-
Number of holders
-
3
-
Value change
-
-$2,259,291
-
Number of sells
-
2
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q4 2023
As of 31 Dec 2023 BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) had 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 995,388 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, BAKER BROS. ADVISORS LP, BRAIDWELL LP, Kynam Capital Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), GEODE CAPITAL MANAGEMENT, LLC, and RP Management, LLC.
This table shows 234 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.